Skip to main content
SpringerLink
Log in

Bioresorbierbare koronare Scaffolds: Zweifel an der Sicherheit bleiben bestehen

Bioresorbable vascular scaffolds: persistent doubts about their safety

  • Journal Club
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Felix CM, Fam JM, Diletti R et al (2016) Mid- to longterm clinical outcomes of the patients treated with everolimus eluting bioresorbable vascular scaffold. The BVS Expand Registry. JACC Cardiovasc Interv 9(16):1652–1663

  2. Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Münzel T, Tamburino C (2015) Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: Early and midterm outcomes from the European multicentre GHOST-EU registry. EuroIntervention 10(10):1144–1153 (Feb)

    Article  PubMed  Google Scholar 

  3. Puricel S, Cuculi F, Weissner M, Schmermund A, Jamshidi P, Nyffenegger T, Binder H, Eggebrecht H, Münzel T, Cook S, Gori T (2016) Bioresorbable coronary scaffold thrombosis: Multicenter comprehensive analysis of clinical presentation, mechanisms, and predictors. J Am Coll Cardiol 67(8):921–931

    Article  PubMed  Google Scholar 

  4. Tan HC, Ananthakrishna R (2016) Bioresorbable vascular scaffolds in routine clinical practice: Should we wait longer? JACC Cardiovasc Interv 9(16):1664–1666

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardioangiologisches Centrum Bethanien (CCB), Im Prüfling 23, 60389, Frankfurt am Main, Deutschland

    H. Eggebrecht

Authors
  1. H. Eggebrecht
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Eggebrecht.

Ethics declarations

Interessenkonflikt

H. Eggebrecht gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eggebrecht, H. Bioresorbierbare koronare Scaffolds: Zweifel an der Sicherheit bleiben bestehen. Kardiologe 10, 341–342 (2016). https://doi.org/10.1007/s12181-016-0088-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-016-0088-y

Search

Navigation